149 related articles for article (PubMed ID: 32220057)
1. Long-term observation of a Japanese mucolipidosis IV patient with a novel homozygous p.F313del variant of MCOLN1.
Hayashi T; Hosono K; Kubo A; Kurata K; Katagiri S; Mizobuchi K; Kurai M; Mamiya N; Kondo M; Tachibana T; Saitsu H; Ogata T; Nakano T; Hotta Y
Am J Med Genet A; 2020 Jun; 182(6):1500-1505. PubMed ID: 32220057
[TBL] [Abstract][Full Text] [Related]
2. Novel compound heterozygous MCOLN1 mutations identified in a Japanese girl with severe developmental delay and thin corpus callosum.
Yamaguchi N; Ban K; Suzuki A; Nakamura Y; Kato K; Muramatsu H; Okuno Y; Hattori A; Kaname T; Takahashi Y; Saitoh S
Brain Dev; 2020 Mar; 42(3):298-301. PubMed ID: 31899079
[TBL] [Abstract][Full Text] [Related]
3. Mucolipidosis IV: A milder form with novel mutations and serial MRI findings.
Shiihara T; Watanabe M; Moriyama K; Maruyama Y; Kikuchi A; Arai-Ichinoi N; Uematsu M; Sameshima K
Brain Dev; 2016 Sep; 38(8):763-7. PubMed ID: 26926398
[TBL] [Abstract][Full Text] [Related]
4. Association of luteal cell degeneration and progesterone deficiency with lysosomal storage disorder mucolipidosis type IV in Mcoln1-/- mouse model†.
Wang Z; El Zowalaty AE; Li Y; Andersen CL; Ye X
Biol Reprod; 2019 Oct; 101(4):782-790. PubMed ID: 31317194
[TBL] [Abstract][Full Text] [Related]
5. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.
Vergarajauregui S; Martina JA; Puertollano R
J Cell Sci; 2011 Feb; 124(Pt 3):459-68. PubMed ID: 21224396
[TBL] [Abstract][Full Text] [Related]
6. The neurogenetics of mucolipidosis type IV.
Altarescu G; Sun M; Moore DF; Smith JA; Wiggs EA; Solomon BI; Patronas NJ; Frei KP; Gupta S; Kaneski CR; Quarrell OW; Slaugenhaupt SA; Goldin E; Schiffmann R
Neurology; 2002 Aug; 59(3):306-13. PubMed ID: 12182165
[TBL] [Abstract][Full Text] [Related]
7. Mucolipidosis type IV.
Bach G
Mol Genet Metab; 2001 Jul; 73(3):197-203. PubMed ID: 11461186
[TBL] [Abstract][Full Text] [Related]
8. Mucolipidosis type IV in a child.
Chaer L; Harissi-Dagher M; Soucy JF; Ellezam B; Hamel P
J AAPOS; 2018 Dec; 22(6):469-471. PubMed ID: 30120981
[TBL] [Abstract][Full Text] [Related]
9. A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.
Mirabelli-Badenier M; Severino M; Tappino B; Tortora D; Camia F; Zanaboni C; Brera F; Priolo E; Rossi A; Biancheri R; Di Rocco M; Filocamo M
Metab Brain Dis; 2015 Jun; 30(3):681-6. PubMed ID: 25156245
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of mucolipidosis type IV.
Slaugenhaupt SA
Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810
[TBL] [Abstract][Full Text] [Related]
11. Mucolipidosis Type IV in Omani Families with a Novel
Al-Alawi B; Harikrishna B; Al-Thihli K; Al Zuhabi S; Ganesh A; Al Hashami Z; Al Dhamhmani Z; Zadjali R; Al Riyami NB; Zadjali F
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205297
[TBL] [Abstract][Full Text] [Related]
12. Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV.
Mepyans M; Andrzejczuk L; Sosa J; Smith S; Herron S; DeRosa S; Slaugenhaupt SA; Misko A; Grishchuk Y; Kiselyov K
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586947
[TBL] [Abstract][Full Text] [Related]
13. MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV.
DeRosa S; Salani M; Smith S; Sangster M; Miller-Browne V; Wassmer S; Xiao R; Vandenberghe L; Slaugenhaupt S; Misko A; Grishchuk Y
Hum Mol Genet; 2021 May; 30(10):908-922. PubMed ID: 33822942
[TBL] [Abstract][Full Text] [Related]
14. Progress in elucidating pathophysiology of mucolipidosis IV.
Misko A; Wood L; Kiselyov K; Slaugenhaupt S; Grishchuk Y
Neurosci Lett; 2021 Jun; 755():135944. PubMed ID: 33965501
[TBL] [Abstract][Full Text] [Related]
15. Autophagic dysfunction in mucolipidosis type IV patients.
Vergarajauregui S; Connelly PS; Daniels MP; Puertollano R
Hum Mol Genet; 2008 Sep; 17(17):2723-37. PubMed ID: 18550655
[TBL] [Abstract][Full Text] [Related]
16. Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.
Vergarajauregui S; Puertollano R
Autophagy; 2008 Aug; 4(6):832-4. PubMed ID: 18635948
[TBL] [Abstract][Full Text] [Related]
17. Loss of lysosomal ion channel transient receptor potential channel mucolipin-1 (TRPML1) leads to cathepsin B-dependent apoptosis.
Colletti GA; Miedel MT; Quinn J; Andharia N; Weisz OA; Kiselyov K
J Biol Chem; 2012 Mar; 287(11):8082-91. PubMed ID: 22262857
[TBL] [Abstract][Full Text] [Related]
18. Shared facial phenotype of patients with mucolipidosis type IV: A clinical observation reaffirmed by next generation phenotyping.
Pode-Shakked B; Finezilber Y; Levi Y; Liber S; Fleischer N; Greenbaum L; Raas-Rothschild A
Eur J Med Genet; 2020 Jul; 63(7):103927. PubMed ID: 32298796
[TBL] [Abstract][Full Text] [Related]
19. Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.
Jezela-Stanek A; Ciara E; Stepien KM
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604955
[TBL] [Abstract][Full Text] [Related]
20. Mucolipidosis type IV in a Turkish boy associated with a novel MCOLN1 mutation.
Tüysüz B; Goldin E; Metin B; Korkmaz B; Yalçinkaya C
Brain Dev; 2009 Oct; 31(9):702-5. PubMed ID: 19006653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
